AVEAVECHO BIOTECHNOLOGY LIMITEDMarket sensitive

Positive interim results from Phase III insomnia program

Date and time
Announcement type
Company Update

More from Health Care

More News

VR8Company Update5 October 2026

Vanadium Resources (ASX: VR8) Maps US$842m V-Iron Case